- Globe Life increased its 2025 operating earnings per share (EPS) forecast to a range of $13.45 to $14.05, previously $13.20 to $13.90.
- The consensus estimate for operating EPS was $13.58.
- For the fourth quarter, Globe Life reported an operating EPS of $3.14, slightly above the estimate of $3.12.
- The adjusted book value per share was reported at $86.40, compared to the estimate of $86.83.
- The book value per share exceeded estimates, reported at $62.50 versus the expected $57.66.
- Total revenue was slightly below expectations, coming in at $1.47 billion against a forecast of $1.48 billion.
- Life insurance premium revenue reached $823.0 million, slightly missing the estimate of $829.2 million.
- Health insurance premium revenue was $358.3 million, marginally under the expected $358.8 million.
- Insurance underwriting income stood at $338.0 million, short of the estimate of $342.4 million.
- Net investment income was reported at $282.5 million, below the anticipated $288.2 million.
- Analyst recommendations for Globe Life include 8 buys, 5 holds, and no sells.
“`
Globe Life on Smartkarma
Analysts from Baptista Research have provided insightful coverage of Globe Life Inc. on Smartkarma, offering varying perspectives on the company’s performance. In the report titled “Globe Life Inc.: An Insight Into Its Strategic Capital Utilization & Other Major Drivers,” Globe Life’s third-quarter earnings report highlighted key operational and financial dynamics, showing promising growth. The company’s net income rose to $303 million or $3.44 per share, marking a significant increase from the previous year, while net operating income reached $308 million or $3.49 per share, reflecting a substantial 29% growth year over year.
In another report by Baptista Research, titled “Globe Life Inc.: A Bear’s Perspective! – Major Drivers,” the analysts continued to showcase Globe Life’s strong performance. In the second quarter of 2024, the company reported a net income of $258 million, or $2.83 per share, representing an impressive growth of around 20% from the previous year. The net operating income also saw a notable increase to $271 million or $2.97 per share, indicating a robust improvement in profitability and underscoring the company’s operational efficiency and financial strength.
A look at Globe Life Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have assessed Globe Life’s long-term outlook using a range of factors. With a strong Growth score of 4 and impressive Momentum score of 4, Globe Life appears positioned for future expansion and sustained performance in the market. This indicates a positive trajectory for the company’s development and the potential for continued growth opportunities in its sector.
While Globe Life received solid scores for Value at 3 and Resilience at 3, the company scored lower in the Dividend category with a score of 2. This suggests that investors seeking high dividend payouts may need to consider this aspect carefully. Overall, with favorable ratings in Growth and Momentum, Globe Life demonstrates promising indicators for long-term success in its operations as an insurance provider in the State of Texas.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
